Publication:
Safety and efficacy of ponatinib in real world clinical practice. Results from the Spanish Compassionate Use Program. A GELMC study

dc.contributor.authorValentin, GG
dc.contributor.authorHernandez-Boluda, JC
dc.contributor.authorOsorio, S
dc.contributor.authorCorrea, JG
dc.contributor.authorSanchez-Guijo, F
dc.contributor.authorGómez-Casares, MT
dc.contributor.authorDurán, S
dc.contributor.authorPortero, MA
dc.contributor.authorBoqué, C
dc.contributor.authorPérez-Encinas, M
dc.contributor.authorMata, MI
dc.contributor.authorRomo, MA
dc.contributor.authorVallansot, R
dc.contributor.authorPayer, A
dc.contributor.authorNoya, MS
dc.contributor.authorCaballero, G
dc.contributor.authorRamirez Sánchez, MJ
dc.contributor.authorJimenez-Velasco, A
dc.contributor.authorSteegmann, JL
dc.contributor.authoraffiliation[Valentin,GG] Servicio de Hematología, Hospital Universitario Ramón y Cajal, Madrid. [Hernández-Boluda,JC] Servicio de Hematología, Hospital Clínico, Valencia. [Osorio,S] Servicio de Hematología, Hospital Universitario Gregorio Marañon, Madrid. [Correa,JG] Servicio de Hematología, Hospital Clinic, Barcelona. [Sanchez-Guijo,F] Servicio de Hematología, Hospital Universitario de Salamanca, Salamanca. [Gómez-Casares,MT] Servicio de Hematología, Hospital Universitario Dr Negrin, Gran Canaria. [Durán,S] Servicio de Hematología, Hospital Médico Quirúrgico de Jaen, Jaen. [Portero,MA] Servicio de Hematología, Hospital Universitario Virgen Macarena, Sevilla. [Boqué,C] Servicio de Hematología, ICO-Hospital Duran I Reynals. Hospitaletdel Llobregat, Barcelona. [Pérez-Encinas,M] Servicio de Hematología, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela. [Mata,MI] Servicio de Hematología, Hospital Costa del Sol, Marbella, Málaga. [Romo,MA] Servicio de Hematología, Hospital Meixoeiro, Vigo, Vigo. [Vallansot,R] Servicio de Hematología, Hospital Juan XXIII, Tarragona. [Payer,A] Servicio de Hematología, Hospital Universitario Central de Asturias, Oviedo. [Noya,MS] Servicio de Hematología, Complejo Hospitalario Universitario A Coruña, La Coruña. [Caballero,G] Servicio de Hematologia, Hospital Universitario Miguel Servet, Zaragoza. [Ramirez Sánchez,MJ] Servicio de Hematologia, Hospital del SAS de Jérez de la Frontera, Cádiz. [Jimenez-Velasco,A] Servicio de Hematologia, Servicio de Hematología, Hospital Regional Universitario Carlos Haya, Málaga. [Steemann,JL] Servicio de Hematología y IIS-IP, Hospital Universitario de la Princesa, Madrid, Spain.es
dc.date.accessioned2016-10-03T10:11:29Z
dc.date.available2016-10-03T10:11:29Z
dc.date.issued2016-06
dc.description.abstractAims: The purpose of this study is to provide safety and efficacy information from patients treated with ponatinib in real world clinical practice.es
dc.description.versionNoes
dc.identifier.citationValentin GG, Hernandez-Boluda JC, Osorio S, Correa JG, Sanchez-Guijo F, Gómez-Casares MT, et al.Safety and efficacy of ponatinib in real world clinical practice. Results from the Spanish Compassionate Use Program. A GELMC study. Haematologica. 2016; 101 (s1) PB1832es
dc.identifier.essn1592-8721
dc.identifier.issn0390-6078
dc.identifier.urihttp://hdl.handle.net/10668/2441
dc.journal.titleHaematologica
dc.language.isoen
dc.organizationAGS Jerez, Costa Noroeste y Sierra de Cádiz
dc.publisherFerrata Storti Foundationes
dc.relation.publisherversionhttp://www.haematologica.org/content/101/s1es
dc.rights.accessRightsopen access
dc.subjectHumanoses
dc.subjectImidazoleses
dc.subjectLeucemia mielogenosa crónica BCR-ABL positivaes
dc.subjectPiridacinases
dc.subjectRiesgoes
dc.subject.meshMedical Subject Headings::Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humanses
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Azoles::Imidazoleses
dc.subject.meshMedical Subject Headings::Diseases::Hemic and Lymphatic Diseases::Hematologic Diseases::Bone Marrow Diseases::Myeloproliferative Disorders::Leukemia, Myelogenous, Chronic, BCR-ABL Positivees
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Heterocyclic Compounds::Heterocyclic Compounds, 1-Ring::Pyridazineses
dc.subject.meshMedical Subject Headings::Health Care::Health Care Quality, Access, and Evaluation::Quality of Health Care::Health Care Evaluation Mechanisms::Statistics as Topic::Probability::Riskes
dc.titleSafety and efficacy of ponatinib in real world clinical practice. Results from the Spanish Compassionate Use Program. A GELMC studyes
dc.typeconference presentation
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
ValentinGG_SafetyAndEfficacyOfPonatinib.pdf
Size:
85.12 KB
Format:
Adobe Portable Document Format
Description:
Abstract